![Neil McFarlane](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Neil McFarlane
Verkställande Direktör på
ZEVRA THERAPEUTICS, INC.
Förmögenhet: 3 M $ per 2026-07-31
Profil
Neil F.
McFarlane is President, Chief Executive Officer & Director at Zevra Therapeutics, Inc. since 2023.
Former roles include Chief Executive Officer at Adamas Pharmaceuticals LLC from 2019 to 2021, Independent Director at Collegium Pharmaceutical, Inc. from 2022 to 2024, Vice President & General Manager at UCB, Inc. from 2011 to 2016, and Chief Operating Officer at Travere Therapeutics, Inc. from 2016 to 2019.
Education includes undergraduate and graduate degrees from the University of Florida.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ZEVRA THERAPEUTICS, INC. 0,51 % | 2026-04-06 | 304 282 ( 0,51 % ) | 3 M $ | 2026-07-31 |
Aktiva positioner av Neil McFarlane
| Företag | Position | Start |
|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Verkställande Direktör | 2023-10-10 |
Tidigare kända positioner av Neil McFarlane
| Företag | Position | Slut |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Direktör/Styrelseledamot | 2024-07-28 |
| ADAMAS PHARMACEUTICALS, INC. | Verkställande Direktör | 2021-11-01 |
| TRAVERE THERAPEUTICS, INC. | Verksamhetschef | 2019-05-31 |
UCB, Inc.
 UCB, Inc. Financial ConglomeratesFinance Provides financial services | Företagsledare/Principal | 2016-01-01 |
Neil McFarlanes utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
54
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Collegium Pharmaceutical, Inc.
 Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Zevra Therapeutics, Inc.
 Zevra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets proprietary prodrugs | Health Technology |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Finance |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
